Source: Orthopedics This Week
The U.S. Food and Drug Administration (FDA) has approved a request for a supplemental Biologics License Application for the repair of knee cartilage defects using arthroscopic delivery of the autologous cultured chondrocytes on a porcine collagen membrane.
